ES2075900T3 - Composiciones estables de vacuna que contienen interleucinas. - Google Patents
Composiciones estables de vacuna que contienen interleucinas.Info
- Publication number
- ES2075900T3 ES2075900T3 ES90911344T ES90911344T ES2075900T3 ES 2075900 T3 ES2075900 T3 ES 2075900T3 ES 90911344 T ES90911344 T ES 90911344T ES 90911344 T ES90911344 T ES 90911344T ES 2075900 T3 ES2075900 T3 ES 2075900T3
- Authority
- ES
- Spain
- Prior art keywords
- vaccine compositions
- compositions containing
- interleukin
- mineral
- interleukins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A61K2039/55527—Interleukins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
ESTA INVENCION DESCRIBE COMPOSICIONES DE VACUNAS CONTENIENDO INTERLEUCINAS , COMPRENDIENDO UNA MEZCLA DE ANTIGENO Y UNA CANTIDAD ADYUVANTE DE UNA INTERLEUCINA ABSORVIDA EN UN MINERAL EN SUSPENSION Y UN PRESERVATIVO. PREFERENTEMENTE, EL MINERAL ES ALUMINIO. LA INTERLEUCINA PUEDE MODULAR LA RESPUESTA INMUNOPROTECTORA A UN ANTIGENO, MIENTRAS QUE EL MINERAL ESTABILIZA LA ACTIVIDAD BIOLOGICA DE LA INTERLEUCINA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37974289A | 1989-07-14 | 1989-07-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2075900T3 true ES2075900T3 (es) | 1995-10-16 |
Family
ID=23498494
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES90911344T Expired - Lifetime ES2075900T3 (es) | 1989-07-14 | 1990-07-16 | Composiciones estables de vacuna que contienen interleucinas. |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0482076B1 (es) |
JP (2) | JP3485184B2 (es) |
KR (1) | KR0177179B1 (es) |
AT (1) | ATE121629T1 (es) |
AU (1) | AU648509B2 (es) |
CA (1) | CA2063587C (es) |
DE (1) | DE69018990T2 (es) |
DK (1) | DK0482076T3 (es) |
ES (1) | ES2075900T3 (es) |
FI (1) | FI104233B (es) |
NO (1) | NO301577B1 (es) |
WO (1) | WO1991001143A1 (es) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991006319A1 (en) * | 1989-10-27 | 1991-05-16 | Arch Development Corporation | Methods and compositions for promoting immunopotentiation |
US6406696B1 (en) | 1989-10-27 | 2002-06-18 | Tolerance Therapeutics, Inc. | Methods of stimulating the immune system with anti-CD3 antibodies |
GR1000881B (el) * | 1990-08-06 | 1993-03-16 | Praxis Biolog Inc | Σταθερες συνθεσεις εμβολιου που περιεχουν ιντερλευκινες. |
CZ119993A3 (en) * | 1990-12-19 | 1994-02-16 | Schering Corp | The use of il-4 for increasing immune response to immunogens in vaccines |
CA2109316A1 (en) * | 1991-05-13 | 1992-11-14 | Edward Abraham | Liposomal polysaccharide vaccines |
DE4126983A1 (de) | 1991-08-15 | 1993-02-18 | Boehringer Mannheim Gmbh | Verfahren zur herstellung von humanprotein-enthaltenden, konservierten arzneimitteln fuer infusions- oder injektionszwecke |
WO1994003202A1 (en) * | 1992-08-10 | 1994-02-17 | The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services | Interleukin-4 stimulated t lymphocyte cell death |
ZA936095B (en) * | 1992-08-21 | 1994-03-14 | Univ Melbourne | Cytokine applications. |
US6491916B1 (en) | 1994-06-01 | 2002-12-10 | Tolerance Therapeutics, Inc. | Methods and materials for modulation of the immunosuppresive activity and toxicity of monoclonal antibodies |
AU3541495A (en) * | 1994-09-01 | 1996-03-22 | Wisconsin Alumni Research Foundation | Therapeutic remodeling in aids |
US6509313B1 (en) * | 1996-02-28 | 2003-01-21 | Cornell Research Foundation, Inc. | Stimulation of immune response with low doses of cytokines |
ES2262181T3 (es) * | 1996-05-31 | 2006-11-16 | National University Of Ireland, Maynooth | Il-12 como adyuvante en la vacuna contra la especie bordetella pertussis. |
TW586934B (en) * | 1997-05-19 | 2004-05-11 | Sumitomo Pharma | Immunopotentiating composition |
US6270758B1 (en) | 1998-10-08 | 2001-08-07 | Duke University | Substantially non-toxic biologically active mucosal adjuvants in vertebrate subjects |
US6027731A (en) * | 1998-11-17 | 2000-02-22 | Wisconsin Alumni Research Foundation | Pertussis toxin induced lymphocytosis |
IT1302534B1 (it) | 1998-12-21 | 2000-09-05 | Fidia Advanced Biopolymers Srl | Composizioni iniettabili, biocompatibili e biodegradabili comprendentialmeno un derivato dell'acido ialuronico, cellule condrogeniche, per |
SK782002A3 (en) * | 1999-07-21 | 2003-08-05 | Lexigen Pharm Corp | FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens |
AU1813701A (en) | 1999-12-03 | 2001-06-12 | Celltech Chiroscience Limited | Interleukin-1 muteins useful as vaccine adjuvants |
JP2009500457A (ja) | 2005-07-11 | 2009-01-08 | マクロジェニクス,インコーポレーテッド | 毒性の低下した免疫抑制モノクローナル抗体を使用する自己免疫疾患の治療法 |
ES2374648T3 (es) * | 2005-09-30 | 2012-02-20 | Lipoxen Technologies Limited | Composiciones de vacunas liposómicas que comprenden un antígeno polisacárido y un adyuvante proteico. |
EP2037961B1 (en) | 2006-06-14 | 2015-11-11 | MacroGenics, Inc. | Methods for the treatment of autoimmune disorders using monoclonal antibodies with reduced toxicity |
AU2008226974B2 (en) * | 2007-03-09 | 2013-08-15 | Merck Sharp & Dohme Llc | Papillomavirus vaccine compositions |
ES2641375T3 (es) * | 2012-11-02 | 2017-11-08 | Cytuvax | Composición que comprende macroagregados de citoquinas |
JOP20190242A1 (ar) * | 2018-10-12 | 2020-04-12 | Serum Institute Of India Pvt Ltd | تركيبة لقاح توليفي تشمل فيروس شلل الأطفال ذو جرعة مخفّضة خاملة التنشيط وطريقة لتحضيرها |
CN113365650A (zh) | 2018-11-16 | 2021-09-07 | 新免疫技术有限公司 | 用il-7蛋白和免疫检查点抑制剂的组合***的方法 |
JP2023512456A (ja) | 2020-01-13 | 2023-03-27 | ネオイミューンテック, インコーポレイテッド | Il-7タンパク質と二重特異性抗体の組み合わせで腫瘍を治療する方法 |
AU2021217373A1 (en) | 2020-02-05 | 2022-08-04 | Neoimmunetech, Inc. | Method of treating a solid tumor with a combination of an IL-7 protein and CAR-bearing immune cells |
WO2022093718A1 (en) | 2020-10-26 | 2022-05-05 | Neoimmunetech, Inc. | Methods of inducing stem cell mobilization |
KR20230104176A (ko) | 2020-11-02 | 2023-07-07 | 네오이뮨텍, 인코퍼레이티드 | 코로나바이러스의 치료를 위한 인터류킨-7의 용도 |
CA3195594A1 (en) | 2020-11-05 | 2022-05-12 | Byung Ha Lee | Method of treating a tumor with a combination of an il-7 protein and a nucleotide vaccine |
WO2023130081A1 (en) | 2021-12-30 | 2023-07-06 | Neoimmunetech, Inc. | Method of treating a tumor with a combination of il-7 protein and vegf antagonist |
WO2024102722A1 (en) | 2022-11-07 | 2024-05-16 | Neoimmunetech, Inc. | Methods of treating a tumor with an unmethylated mgmt promoter |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2849632B2 (ja) * | 1988-04-08 | 1999-01-20 | 社団法人北里研究所 | ワクチン製剤 |
DE3818054C2 (de) * | 1988-05-27 | 1994-02-17 | Biotest Pharma Gmbh | Verwendung einer Kombination aus einem Antigen bzw. einer Vakzine und humanem Interleukin zur Behandlung der Non-Responsiveness gegenüber immunologischen Defektzuständen |
JPH0236129A (ja) * | 1988-07-22 | 1990-02-06 | Ajinomoto Co Inc | ワクチン効果増強剤 |
-
1990
- 1990-07-16 KR KR1019920700086A patent/KR0177179B1/ko not_active IP Right Cessation
- 1990-07-16 AU AU60500/90A patent/AU648509B2/en not_active Ceased
- 1990-07-16 CA CA002063587A patent/CA2063587C/en not_active Expired - Fee Related
- 1990-07-16 JP JP51060090A patent/JP3485184B2/ja not_active Expired - Fee Related
- 1990-07-16 DK DK90911344.1T patent/DK0482076T3/da active
- 1990-07-16 DE DE69018990T patent/DE69018990T2/de not_active Expired - Fee Related
- 1990-07-16 EP EP90911344A patent/EP0482076B1/en not_active Expired - Lifetime
- 1990-07-16 WO PCT/US1990/003982 patent/WO1991001143A1/en active IP Right Grant
- 1990-07-16 ES ES90911344T patent/ES2075900T3/es not_active Expired - Lifetime
- 1990-07-16 AT AT90911344T patent/ATE121629T1/de not_active IP Right Cessation
-
1992
- 1992-01-13 NO NO920161A patent/NO301577B1/no unknown
- 1992-01-13 FI FI920132A patent/FI104233B/fi not_active IP Right Cessation
-
2003
- 2003-07-31 JP JP2003284148A patent/JP2004002463A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2063587C (en) | 2005-08-30 |
DE69018990D1 (de) | 1995-06-01 |
DK0482076T3 (da) | 1995-07-17 |
AU648509B2 (en) | 1994-04-28 |
JPH04506663A (ja) | 1992-11-19 |
JP2004002463A (ja) | 2004-01-08 |
NO920161L (no) | 1992-03-05 |
FI104233B1 (fi) | 1999-12-15 |
AU6050090A (en) | 1991-02-22 |
ATE121629T1 (de) | 1995-05-15 |
NO920161D0 (no) | 1992-01-13 |
WO1991001143A1 (en) | 1991-02-07 |
FI104233B (fi) | 1999-12-15 |
EP0482076B1 (en) | 1995-04-26 |
JP3485184B2 (ja) | 2004-01-13 |
EP0482076A1 (en) | 1992-04-29 |
DE69018990T2 (de) | 1995-12-14 |
CA2063587A1 (en) | 1991-01-15 |
KR920703103A (ko) | 1992-12-17 |
FI920132A0 (fi) | 1992-01-13 |
KR0177179B1 (ko) | 1999-03-20 |
NO301577B1 (no) | 1997-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2075900T3 (es) | Composiciones estables de vacuna que contienen interleucinas. | |
FI945483A (fi) | Hepatiitti B - pinta-antigeenejä ja muita antigeenejä sisältäviä yhdistelmärokotteita | |
MX9304089A (es) | Uso de gm-csf como una vacuna adyuvante. | |
DK400181A (da) | Sammensatte materialer indeholdende immobiliserede biologisk aktive arter fremgangsmaade til deres fremstilling samt deres anvendelse | |
GB2210557B (en) | Vaccine containing tumor antigens and refined detoxified endotoxin as an adjuvant. | |
CA2231603A1 (en) | Chicken interleukin-15 and uses thereof | |
ES2092306T3 (es) | Adyuvante para vacunas. | |
EA199700272A1 (ru) | Вакцины, содержащие сапонин и стерин | |
IT8322155A0 (it) | Procedimento per immobilizzare materie biologiche e composto di materie biologiche adsorbite in vermiculite. | |
DK0787112T3 (da) | Aerogelholdig sammensætning, fremgangsmåde til dens fremstilling samt dens anvendelse | |
MX9803290A (es) | Composiciones de la vacuna influenza. | |
DE3482907D1 (de) | Verwendung des diterpen-derivates forskolin zur immunstimulation. | |
ES2109254T3 (es) | Proteinas antigenas y vacunas que las contienen para la prevencion de cocidiosis. | |
PT90710A (pt) | Processo para a preparacao de silica para composicoes dentifricas compativel designadamente com zinco | |
ATE61937T1 (de) | Antigenische zubereitungen und isolierung von solchen zubereitungen. | |
SE8404707L (sv) | Komposition innehallande pyridinlosligt extrakt och raffinerat detoxifierat endotoxin samt anvendning derav | |
EP0722338A4 (en) | PROTEIN OR PEPTIDE COCHLEATE VACCINES AND IMMUNIZATION METHODS USING THE SAME | |
ATE275421T1 (de) | Interleukin-12 und herpes simplex virusantigen enthaltende impfstoffe | |
JPS57116100A (en) | Novel d-homosteroid | |
JPS55106261A (en) | Composition made of dispersed body of colloid silica and colloid titania | |
ES2056378T3 (es) | Procedimiento de extraccion. | |
GB2227936A (en) | Vaccine against brucella abortus | |
GR1000881B (el) | Σταθερες συνθεσεις εμβολιου που περιεχουν ιντερλευκινες. | |
ES2096559T3 (es) | Interferon gamma humano, procedimiento para la preparacion de dicho interferon gamma humano, y su uso. | |
ATE102038T1 (de) | Eliminierung von aktivierten lymphozyten. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 482076 Country of ref document: ES |